NCT02718924

Brief Summary

Investigators hypothesized that the impact of surgery in terms of inducing a hypercoagulable state is more evident in morbidly obese pregnant women as opposed to their non-obese counterparts. The aim of this study is to investigate the change in coagulation status of morbidly obese and non-obese pregnant women following cesarean section delivery using thromboelastometry. This observational study would also make it possible to calculate the sample size for a future prospective controlled clinical trial to compare the incidence of Hypercoagulability in morbidly obese parturients as opposed to their non-obese counterparts. To the best of our knowledge, no other work has been done any in this area.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 24, 2016

Completed
8 months until next milestone

Study Start

First participant enrolled

November 15, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2017

Completed
Last Updated

November 8, 2018

Status Verified

November 1, 2018

Enrollment Period

11 months

First QC Date

January 17, 2016

Last Update Submit

November 7, 2018

Conditions

Keywords

Thromboelastometrypregnancyobesity

Outcome Measures

Primary Outcomes (1)

  • Calculated clot strength using EXTEM Maximum Clot Firmness (G value for EXTEM)

    "G" value will be calculated according to the formula: (5000xMCF)/100-MCF and expressed as dynes/cm2

    8 hours

Secondary Outcomes (5)

  • EXTEM clotting time and clot formation time in seconds.

    8 hours

  • EXTEM maximum clot firmness in millimeters

    8 hours

  • INTEM clotting time and clot formation time in seconds.

    8 hours

  • INTEM maximum clot firmness in millimeters

    8 hours

  • FIBTEM maximum clot firmness in millimeters

    8 hours

Study Arms (2)

morbidly obese pregnant

Term pregnant women with BMI more than 40

non obese pregnant

Term pregnant women with BMI less than 30

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Term pregnant women presenting for elective cesarean section under spinal anaesthesia

You may qualify if:

  • pregnant women at term presenting for cesarean section under spinal anaesthesia with BMI less than 30 and more than 40

You may not qualify if:

  • Patients with BMI between 30 and 40 BMI
  • Patients with a history of past or current thromboembolism.
  • Patients with history of liver disease and those on anticoagulant/anti-platelet therapy
  • Patients who requires perioperative blood transfusion
  • Patients having General anaesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Corniche Hospital

Abu Dhabi, 3788, United Arab Emirates

Location

MeSH Terms

Conditions

ObesityThrombophilia

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsHematologic DiseasesHemic and Lymphatic Diseases

Study Officials

  • Mohamed Samy Abdel Raheem, FRCA

    Consultant Anaesthetist

    PRINCIPAL INVESTIGATOR
  • Tarek Ansari, FFARCSI

    Consultant Anaesthetist

    PRINCIPAL INVESTIGATOR
  • Waleed Riad, MD

    Consultant Anaesthetist

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 17, 2016

First Posted

March 24, 2016

Study Start

November 15, 2016

Primary Completion

September 30, 2017

Study Completion

October 30, 2017

Last Updated

November 8, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will not share

No plan

Locations